Antipsychotics and Torsadogenic Risk: Signals Emerging from the US FDA Adverse Event Reporting System Database

Drug-induced arrhythmia: pharmacogenomic prescribing?

(2012) E. R. Behr et al.   EUROPEAN HEART JOURNAL

Data-Driven Prediction of Drug Effects and Interactions

(2012) N. P. Tatonetti et al.   Science Translational Medicine

QT interval shortening in spontaneous reports submitted to the FDA: the need for consensus

(2011) Emanuel Raschi et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Assessing QT Interval Prolongation and its Associated Risks with Antipsychotics

(2011) Jimmi Nielsen et al.   CNS DRUGS

Aripiprazole

(2011) Sohita Dhillon   DRUGS

QT prolongation of the antipsychotic risperidone is predominantly related to its 9-hydroxy metabolite paliperidone

(2011) Yutaro Suzuki et al.   HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL

Prolongation of Cardiac Ventricular Repolarization Under Paliperidone: How and How Much?

(2011) Patrick Vigneault et al.   JOURNAL OF CARDIOVASCULAR PHARMACOLOGY

Sudden Deaths in Psychiatric Patients

(2011) Peter Manu et al.   JOURNAL OF CLINICAL PSYCHIATRY

Spontaneous adverse event reports of Stevens-Johnson syndrome/toxic epidermal necrolysis: detecting associations with medications

(2011) Julie Papay et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Increasing off-label use of antipsychotic medications in the United States, 1995-2008

(2011) G. C. Alexander et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Comparative safety of antipsychotics in the WHO pharmacovigilance database: the haloperidol case

(2011) Carla Meyer-Massetti et al.   International Journal of Clinical Pharmacy

Prevention of Torsade de Pointes in Hospital Settings

(2010) Barbara J. Drew et al.   CIRCULATION

Antimicrobials and the Risk of Torsades de Pointes

(2010) Elisabetta Poluzzi et al.   DRUG SAFETY

Evaluation of the effect of paliperidone extended release and quetiapine on corrected QT intervals

(2010) David W. Hough et al.   INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY

Amisulpride Overdose Is Frequently Associated With QT Prolongation and Torsades de Pointes

(2010) Geoffrey K. Isbister et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Cyamemazine metabolites: effects on human cardiac ion channels in-vitro and on the QTc interval in guinea pigs

(2010) William Crumb et al.   JOURNAL OF PHARMACY AND PHARMACOLOGY

Effects on prolongation of Bazett’s corrected QT interval of seven second-generation antipsychotics in the treatment of schizophrenia: a meta-analysis

(2010) Albert KK Chung et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Drug-Induced Long QT Syndrome

(2010) P. Kannankeril et al.   PHARMACOLOGICAL REVIEWS

Antipsychotic prescribing trends: a review of pharmaco-epidemiological studies

(2009) H. Verdoux et al.   ACTA PSYCHIATRICA SCANDINAVICA

Sudden death in patients receiving drugs tending to prolong the QT interval

(2009) Kate Jolly et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Drug-induced QT interval shortening: potential harbinger of proarrhythmia and regulatory perspectives

(2009) Rashmi R Shah   BRITISH JOURNAL OF PHARMACOLOGY

hERG-related drug toxicity and models for predicting hERG liability and QT prolongation

(2009) Emanuel Raschi et al.   Expert Opinion on Drug Metabolism & Toxicology

Atypical Antipsychotic Drugs and the Risk of Sudden Cardiac Death

(2009) Wayne A. Ray et al.   NEW ENGLAND JOURNAL OF MEDICINE

Quantitative signal detection using spontaneous ADR reporting

(2009) A. Bate et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Drug-induced torsades de pointes: data mining of the public version of the FDA Adverse Event Reporting System (AERS)

(2009) Elisabetta Poluzzi et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Differences in psychotropic drug prescriptions among ethnic groups in the Netherlands

(2009) Laura Christina Wittkampf et al.   SOCIAL PSYCHIATRY AND PSYCHIATRIC EPIDEMIOLOGY

Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis

(2008) Stefan Leucht et al.   LANCET

Epidemiologic Features of Antipsychotic Prescribing to Children and Adolescents in Primary Care in the United Kingdom

(2008) F. Rani et al.   PEDIATRICS